These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sandimmun neoral improves the bioavailability of cyclosporin A and decreases inter-individual variations in patients affected with cystic fibrosis. Girault D; Haloun A; Viard L; Bellon G; Gottrand F; Guillemain R; Lenoir G; Ladurie FL; Plouvier E; Storni V Transplant Proc; 1995 Aug; 27(4):2488-90. PubMed ID: 7652899 [No Abstract] [Full Text] [Related]
3. Pharmacokinetics of cyclosporine A in bilateral lung transplantation candidates with cystic fibrosis. Mancel-Grosso V; Bertault-Peres P; Barthelemy A; Chazalette JP; Durand A; Noirclerc M Transplant Proc; 1990 Aug; 22(4):1706-7. PubMed ID: 2389438 [No Abstract] [Full Text] [Related]
4. Pharmacokinetic profile and variability of cyclosporine versus neoral in patients with cystic fibrosis after lung transplantation. Kesten S; Scavuzzo M; Chaparro C; Szalai JP Pharmacotherapy; 1998; 18(4):847-50. PubMed ID: 9692659 [TBL] [Abstract][Full Text] [Related]
5. Altered pharmacokinetics of cyclosporin in heart-lung transplant recipients with cystic fibrosis. Tan KK; Hue KL; Strickland SE; Trull AK; Smyth RL; Scott JP; Kelman AW; Whiting B; Higenbottam TW; Wallwork J Ther Drug Monit; 1990 Nov; 12(6):520-4. PubMed ID: 2274997 [TBL] [Abstract][Full Text] [Related]